Le Lézard
Classified in: Health
Subjects: HEALTH, Philanthropy

Diabetes Canada awards over $6 million in funding to new research projects


Toronto, Ontario, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to dramatically improve the lives of people living with or at risk of type 1 and type 2 diabetes through innovative research. Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.

"To achieve our vision of a world free of the effects of diabetes, Diabetes Canada knows that it needs to harness the transformative and combined power of technological, medical, and scientific research," says Laura Syron, President and CEO of Diabetes Canada. "Since 1975, this research grant competition has helped ensure that Canada is a global leader in research into new breakthroughs in diabetes screening, treatments and care to help improve the lives of the nearly 12 million people in Canada who live with diabetes or prediabetes."

Spanning biomedical, clinical, health services and population health research, each winning project has the potential to unlock new insights and breakthroughs in the field of diabetes management, care, and risk-reduction. Among the exciting projects funded in this year's competition, here are a few highlights:

The winning research projects for this year's Diabetes Canada's End Diabetes Awards were rigorously evaluated by scientists with expertise in diabetes research, with input from people with lived experience, and Diabetes Canada's National Research Council.

"The most important part of practicing medicine is when we can use evidence-based ways to inform care and intervene to improve the lives of individuals who live with health issues like diabetes?that doesn't happen without research. Diabetes Canada funding makes research and therefore healthcare possible, directly benefiting people living with diabetes," says Dr. Brandy Wicklow, Co-Chair of Diabetes Canada's National Research Council.

For almost 50 years, Diabetes Canada has proudly supported outstanding diabetes research in Canada, administering more than $160 million in research grants, awards and partnerships to scientists and clinicians who have dedicated their careers to the fight against diabetes.

"We are grateful for the support of our incredible community of donors, without which this research funding would not be possible. On behalf of Diabetes Canada and the nearly 1 in 3 people who live with diabetes or prediabetes in this country, your meaningful investment in the health of those who live with diabetes is making an impact," says Syron, who lives with type 2 diabetes herself.

Currently, Diabetes Canada's financial commitment to research supports over 260 researchers at 20 different research institutions across the country.

Watch our video announcement featuring Laura Syron, President and CEO of Diabetes Canada. 

Learn more about this year's winning research projects.

About Diabetes Canada

A world free of the effects of diabetes is our vision. That's why we're working together to improve the quality of life of people living with diabetes. We're sharing knowledge and creating connections for individuals and the health-care professionals who care for them; advocating through public policy; and funding research to improve treatments and find a cure to end diabetes.??

Attachment



These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: